Member Info for Energyshares

Top Clit
****e Troll

First of a large pipeine of preCISION drugs nearing completion of Phase 1 trial
FDA authority to start trials in US
T Mac platform about to start
Major collaborations with Large companies

HUA approval in Europe and working on APAC region for the best Covid test in the world.

And we sit a couple of pence above placing on the Dick Turpin market.

Don’t sell hold for gold wait for Nasdaq

DYOR

If anyone wants to buy some self use Meduflow tests.
Medusa marketing machine has started grab yourself 10% discount with this voucher code.

https://www.couponwcode.com/coupons/medusa19.com?cp=0000016046872

Every day contracts like this below are posted on the EU contract page.
Avacta/ Medusa Meduflow Now meets all criteria to apply for these contracts.

Revenue will start to move now.
Well done Avacta & Medusa Go get them……

I have translated page.

https://ted.europa.eu/udl?uri=TED:NOTICE:655904-2021:TEXT:EN:HTML&src=0

Short description:
Due to the ongoing corona pandemic, the state of North Rhine-Westphalia, represented by the President of the Higher Regional Court of Hamm, awards as a framework agreement the delivery of nasal antigen self-tests for self-use by laypeople to detect SARS-CoV-2 for those in the district of the Oberlandesges judicial authorities located in Hamm (excluding penal institutions) from 01.02.2022.
Further details can be found in the description of services and the draft contract.
II.1.5)
Estimated total value
Value excluding VAT: 5 720 000.00 EUR
II.1.6)
Information about lots
This contract is divided into lots: no
II.2)
Description
II.2.2)
Additional CPV code (s)
33124100 Diagnostic devices
33190000 Miscellaneous medical devices and products
II.2.3)
Place of performance
NUTS code: DEA North Rhine-Westphalia
II.2.4)
Description of the procurement:
The subject of the Europe-wide award procedure is the procurement of nasal antigen self-tests for self-application by laypeople for direct pathogen detection of the coronavirus SARS-CoV-2 and their distribution in the individually required quantities to the 129 judicial facilities in the district of the Higher Regional Court of Hamm. The individual judicial authorities and their addresses can be found in Appendix 1 of the description of services.
A nasal test is required as an antigen self-test for the detection of SARS-CoV-2, which provides for the removal in the anterior nasal area. The result of the antigen self-test for the detection of SARS-CoV-2 must be immediately readable by the user of the self-test after approx. 15 minutes.
In addition, the self-tests must have the following properties at the time of delivery, which must also result from the enclosed instructions for use:
a) Sensitivity of at least 95%
b) specificity of at least 99%
c) Shelf life: at least one year from delivery
d) CE marking in the regular conformity assessment procedure
e) Packaging size of a maximum of 50 pieces, whereby the components of the test (in particular the associated liquid) must be separable
The self-tests required for the above-mentioned purposes are in-vitro diagnostics (IVD) for personal use. The contractor must ensure that the product offered is marketable for the entire term of the contract in accordance with the requirements of medical product law and that it meets all requirements, particularly when it comes to being placed on the market for the first time.
Further details can be found in the description of services.
II.2.5)
Award criteria
Criteria below
Price
II.2.6)
Estimated value
Value excluding VAT: 5 720 000.00 EUR

After the months of pain, Avacta have just released the news that de risks this company.
Home Use allows Avacta and Medusa to start selling into the vast EU market helps with APAC region and FDA clearance.
Don’t worry about Avacta selling LFD’s and taking its eye of the therapeutics side.
This is why Avacta done the deal with Medusa.
The full force of the BooHoo marketing & Sales team with their global distribution and consumer data is about to be unleashed.

This allows Avacta to start to bring this little lot to clinical trials and boost MCap:
Oncology
Ava6000 plus
preCISION Velcade
preCIDION Paclitaxel
preCISION Oxaliplatin
preCISION Gemcitabine
preCISION Capecitabine
preCISION PARP inhibitor
preCISION PD-1 inhibitor
preCISION AKT inhibitor
preCISION Balixafortide

On top of that lot we have TMAC Programme.
Major licences:
LG Chem worth up to $400m. LG Chem has potentially 8 new products.
multi-target collaboration with LG Chem incorporating Avacta's Affimer XT™ serum half-life extension and LG Chem has Affimer PD-L1 inhibitor totalling $98million
The expanded partnership also provides LG Chem with rights to develop and commercialise other Affimer and non-Affimer biotherapeutics combined with Affimer XT half-life extension for a range of indications and Avacta could earn an additional $55m in milestone payments for each of these new products.
Daewoong x 2
Gene & stem cell with other targets.
Plus a JV with Daewoong AffyXell Therapeutics which was developed by Avacta and Daewoong as a Joint Venture to develop novel mesenchymal stem cell (MSC) therapies.
Point Biopharma, with access to its pre|CISION technology.
Moderna x 1
exclusive license agreement with respect to certain Affimer molecules.
Astrea x 1
Deepverge x 1
Biokit x 1
Abcam x 1
Bioserve x 1

Affidx Portfolio
Covid x 5
Affidx, Bams,Elisa,
Meduflow through Medusa 19 ,Mologic combination test.
Plus in house pipe line non-COVID diagnostic tests, which include assays for D-dimer, cortisol, vitamins D and B12 and CRP.

Look at the big picture it’s Not just about Covid.

Don’t give your Wonka tickets away for a 20% rise
DYOR.

Can anyone else smell shorts burning….

Wyn
Nob D nob
Turtle
Jupiter
Bye………

Medusa have been working optimising their website with Venn digital in the States for their saliva protein test. So they are getting ready for a USA launch.

Sub-folder URL structures for a website, mean anything after the .com or .com/uk/, depending on what your set-up is.
For example, with our clients Medusa 19, we've gone down the localised translated route.
https://www.medusa19.com/es/prueba-rapida-de-proteina-en-saliva/ is the Spanish equivalent for; https://www.medusa19.com/en/rapid-saliva-protein-test/.

https://www.venndigital.co.uk/blog/expanding-into-the-usa-recruitment-boom-venns-international-seo-checklist-275507/

They have also been using the services of another company.
https://www.covidrapidexam.com/

I have posted this before that I filled out the contact form and received this reply straight away.

Message:
Hi ?Are you supplying Medusa antigen test by Avacta (Affidx)?If so when and is it being sold in USA ?Regards ?Bill

Re: Form Submission - Covid Rapid Exam Form

stevecrummey**********

Thanks Bill. We will have FDA approval within 45-60 days.
That was dated 9th November.

Now Michael Mina tweet today:

Nevertheless, I am excited about this development. I think this is very good for start for US and although 500 million across 350 million is not massive per person - this has the ability ensure that this process is in place and the US will have tests when needed beyond Omicron.

Something is brewing……

Big Al gave us two good news RNS’s last Christmas 21st & 23rd let’s see what he pulls out the bag this year…..

I Hope we are not like ODX they tweeted
“Our offices will be closed for the festive holidays from 24 December and will reopen on 5 January 2022.”

In the middle of a pandemic with LFT shortages you couldn’t make it up.
This Government needs to go….

NOW 21
That’s what I call
BULL****
All their greatest Trolling
Including……
“It’s my party and I’ll Troll if I want to”

“All night long” Lionel Ritchie

“Send in the clowns”

Myles I’m just a “Jealous Guy “ John Lennon

“The tears of a clown” Smokey Robinson

And the Sealions greatest hit “It wasn’t me” by Shaggy

Just opened Day 17 on my Avacta Advent calendar, FFS and another ‘F’en
Sealion.

Come on Al putting 12 sealions in one calendar is taking the p155.

I think this one sentence has just bashed the Bishop…

We also continue to work with our partners, Medusa 19 Healthcare, to obtain the CE mark for consumer self-testing for the product which is a critical next step in the commercialisation of the product."

Bella,
4th August last positive update on Affidx and only other news was the we can’t sell RNS.Diagnostic news deffo restricted,
I hope diagnostic division gets sold off and Avacta moves forward with the therapeutic division.

Could Avacta have a takeover bid hence the silence.
Looks they don’t have to tell the market until a firm bid.

What helped foment opposition was a string of shadow bids for FTSE-listed companies. Equiniti, which provides of share registration services, was on the receiving end off several approaches from Siris Capital that became public only after the US private equity house turned hostile. GardaWorld of Canada took the same strategy with an offer for security contractor G4S last year after having had two offers privately rejected. Signature Aviation, the jet servicing group, reportedly received more than ten approaches from two rival bidders in the nine months before it revealed their offers last December.
At the heart of the issue is Rule Two of the Code, which defines the conditions around what needs to be said by whom. It assumes total secrecy unless and until the predator makes firm its intention to bid. Absent leaks and suspicious share prices moves, disclosure to the market becomes mandatory only after the “firm offer” qualification is met.
Contrary to popular belief, “firm” is not a synonym for “serious”. Directors are allowed to keep to keep fully-funded approaches from credible parties secret for as long as the firm commitment to bid is absent. That’s why, whenever outed by a leak or the expended patience of the predator, they will tend to justify previous silence by emphasising the uncertainties being taken into account.

This a paywall so might not work.

https://amp.ft.com/content/8069c138-8f0a-4c63-b197-772122c0b71c

Click on upload submit your result takes you to Saturnpass website

https://agile-test.saturnpass.com

But can’t find which lateral flow test they are using.
Just a picture No identity.

https://agiletestservices.com/products/fit-to-fly-lateral-flow-test

This Agile Life sciences link sounds very positive.
What are the chances Medusa & Agile sharing two addresses:

Agile Life sciences
Kemp House, 160 City Road, London, United Kingdom, EC1V 2NX

Medusa 19 life sciences Ltd
KEMP HOUSE, 160 CITY ROAD, UNITED KINGDOM, LONDON, EC1V 2NX

Agile Life Sciences
Telephone: +44 01925 607277
E-mail: info@agilelifesciences.com
Address: Sci-Tech Daresbury, WA4 4FS

Manufacturer's Devices - Medusa 19 Life Sciences Limited
Address:
The Innovation Centre Sci-tech Daresbury
Keckwick Lane
Daresbury
Cheshire WA4 4FS

On the twelfth day of Christmas?
Big Al sent to me:
?Twelve weeks waiting for HUA.?
Eleven Cancer targets.?
Ten Bagger dreaming.
?Nine Months TT with ABDX ?
Eight shots with LG Chem
Seven AM waking & waiting.?
Six Hospitals trialing.?
Five Golden RNS’s please?
Four Muppets crying daily.?
Three vaccine Jabs later.?
Two Divisions scaling.?
And a Innova with a £3 Billion Lead.

This is a good read explaining the pressures on notified bodies and they are concentrating on the better tests for safety of the public.
Once Affidx is passed for HUA there will be less competition from the Chinese rubbish.

https://ec.europa.eu/health/sites/default/files/md_newregulations/docs/md_2017-746-regulation_2021-amendment_en.pdf

The framework agreement is intended to cover the need for self-tests for the next 1 to 2.5 years. The dynamic and unpredictable development of the pandemic makes reliable calculations difficult.

This is very interesting aswell:

The current requirement of 3G at the workplace could also be extended to 3G + in the future.

Looks good having Saturn pass bolted on.